Kwality Pharmaceuticals Limited announced that the Company's finished dosage form manufacturing facility, Oncology Injectable unit situated at Himachal Pradesh has recently been approved by ANVISA, Brazilian Health Regulatory Authority. The facility is involved in manufacturing, packaging, labeling and testing of dosage forms (sterile injections) for treatment of cancer. After approval from Brazil's National Health Surveillance Agency ANVISA, Kwality Pharma now has access to Brazilian Pharmaceutical Market.

The approval opens the door for the Company to one of the largest markets and fastest growing economies in the world and other 56 Pics members which include Malaysia, Ukraine, Thailand etc.